Cryolife (CRY) 12.29 $CRY CryoLife Announces Release

New Post Public Reply Private Reply Replies (0) Message Board

Jul 13, 2016 at 1:04 PM

Cryolife (CRY) 12.29 $CRY

CryoLife Announces Release Date and Teleconference Call Details for 2016 Second Quarter Financial Results
PR Newswire - Tue Jul 12, 4:30PM CDT
CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2016 second quarter financial results will be released on Monday, July 25, 2016 after the market closes. On Tuesday, July 26, 2016 the Company will hold a teleconference call and live webcast at 8:00 a.m. ET to discuss the results, followed by a question and answer session hosted by J. Patrick Mackin, Chairman, President and Chief Executive Officer of CryoLife, Inc.
CRY: 12.29 (+0.09)

Luminex Closes Nanosphere Buyout, Maintains FY16 View
Zacks Equity Research - Zacks Investment Research - Mon Jul 04, 9:07AM CDT
Luminex Corp (LMNX) has finally closed the acquisition of Nanosphere Inc for $1.70 per share on Jun 30.
MASI: 52.56 (+0.04), LMNX: 22.42 (+0.15), CRY: 12.29 (+0.09), MLAB: 126.22 (-0.76)

IDEXX: International Growth Strong, Currency Woes Persist
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 6:44AM CDT
On Jul 1, we issued an updated research report on Delaware, NJ-based IDEXX Laboratories, Inc. (IDXX).
MASI: 52.56 (+0.04), IDXX: 93.57 (-0.65), CRY: 12.29 (+0.09), MLAB: 126.22 (-0.76)

Masimo's Radius 7 Wearable Monitor Gets FDA 510 (k) Nod
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 3:48PM CDT
Masimo Corporation (MASI) recently announced the receipt of FDA 510 (k) approval for the Radius 7 wearable, tetherless, non-invasive rainbow monitor device.
HYH: 34.31 (-0.33), IRMD: 20.81 (-0.67), MASI: 52.56 (+0.04), CRY: 12.29 (+0.09)

Accuray (ARAY) Receives 510(k) FDA Clearance for Radixact
Zacks Equity Research - Zacks Investment Research - Wed Jun 29, 7:41AM CDT
Accuray Inc (ARAY) recently received the much-awaited 510(k) clearance for its Radixact Treatment delivery platform.
IRMD: 20.81 (-0.67), MASI: 52.56 (+0.04), ARAY: 5.40 (+0.03), CRY: 12.29 (+0.09)

Avinger (AVGR) Looks Good: Stock Adds 5.4% in Session
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 7:40AM CDT
Avinger, Inc. (AVGR) saw its shares rise above 5% in the last trading session.
AVGR: 6.94 (-4.49), CRY: 12.29 (+0.09)

Cepheid (CPHD): New Tests Drive Growth, Competition Rife
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 7:24AM CDT
With respect to pipeline development, Cepheid's (CPHD) Xpert Trichomonas for male urine claim is currently on track for FDA submission.
IRMD: 20.81 (-0.67), MASI: 52.56 (+0.04), CPHD: 33.40 (-0.80), CRY: 12.29 (+0.09)

Luminex Well Poised on Pipeline Strength, Strategic Tie-Ups
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 7:03AM CDT
After posting a strong first quarter of 2016, Luminex (LMNX) is now expected to benefit from its ARIES System and the NxTAG Respiratory Pathogen Panel expansion plans.
IRMD: 20.81 (-0.67), MASI: 52.56 (+0.04), LMNX: 22.42 (+0.15), CRY: 12.29 (+0.09)

Quest Diagnostics Poised on Strategic Tie-Ups, New Launches
Zacks Equity Research - Zacks Investment Research - Mon Jun 27, 6:38AM CDT
On Jun 26, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
HCA: 79.67 (+1.27), MASI: 52.56 (+0.04), DGX: 83.03 (+0.02), CRY: 12.29 (+0.09)

Intuitive Surgical at 52-Week High on High Procedural Volume
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 9:24AM CDT
Share price of Intuitive Surgical (ISRG) rallied to a new 52-week high of $661.94 on Jun 23, eventually closing a tad bit lower at $661.32.
ISRG: 674.22 (-1.09), IRMD: 20.81 (-0.67), MASI: 52.56 (+0.04), CRY: 12.29 (+0.09)

Accuray's (ARAY) TomoTherapy System Uptake on the Rise
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 9:00AM CDT
Accuray Inc.'s (ARAY) TomoTherapy System continues to gain traction in international markets.
IRMD: 20.81 (-0.67), MASI: 52.56 (+0.04), ARAY: 5.40 (+0.03), CRY: 12.29 (+0.09)

Should You Get Rid of Quotient Limited (QTNT) Now?
Zacks Equity Research - Zacks Investment Research - Thu Jun 23, 7:43AM CDT
Quotient Limited has witnessed a significant price decline in the past four weeks and negative estimate revisions, making it time for investors to sell it off.
QTNT: 8.08 (+0.08), CRY: 12.29 (+0.09)

Intuitive Surgical: Forex & Regulatory Woes Continue to Hurt
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 9:06AM CDT
Intuitive Surgical has been facing several headwinds including Foreign exchange headwinds and delayed market acceptance.
ISRG: 674.22 (-1.09), IRMD: 20.81 (-0.67), MASI: 52.56 (+0.04), CRY: 12.29 (+0.09)

Opko Health (OPK) Catches Eye: Stock Adds 5.6% in Session
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:15AM CDT
Opko Health, Inc. (OPK) shares rose almost 6% in the last trading session.
OPK: 9.69 (-0.22), CRY: 12.29 (+0.09)

Strength Seen in Mazor Robotics (MZOR) Stock Soars 10%
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 7:00AM CDT
Mazor Robotics Ltd. (MZOR) was a big mover last session, as the company's shares rose nearly 10% on the day.
MZOR: 20.69 (-0.44), CRY: 12.29 (+0.09)

Stryker (SYK) Hits 52-Week High on Positive FY16 View
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 9:14AM CDT
Share price of Stryker Corp (SYK) rallied to a new 52-week high of $116.99 on Jun 20.
MASI: 52.56 (+0.04), BAX: 46.81 (-0.04), CRY: 12.29 (+0.09), SYK: 122.45 (-0.37)

Thermo Fisher Grows Globally; Affimetrix Synergy on Track
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 7:17AM CDT
On Jun 20, 2016, we issued an updated research report on Thermo Fisher Scientific Inc. (TMO).
MASI: 52.56 (+0.04), TMO: 154.53 (+0.15), CRY: 12.29 (+0.09), MLAB: 126.22 (-0.76)

IRadimed (IRMD) Raised to Strong Buy on Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:18AM CDT
On Jun 17, Zacks Investment Research raised IRadimed Corp. (IRMD) to a Zacks Rank #1 (Strong Buy).
IRMD: 20.81 (-0.67), MASI: 52.56 (+0.04), CRY: 12.29 (+0.09), MLAB: 126.22 (-0.76)

Accuray Wins 7 TomoTherapy Orders from NHS, Stock Up
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 7:15AM CDT
Accuray (ARAY) recently won seven TomoTherapy System orders from NHS Supply Chain in the U.K.
IRMD: 20.81 (-0.67), MASI: 52.56 (+0.04), ARAY: 5.40 (+0.03), CRY: 12.29 (+0.09)

Varian Medical Clinches TrueBeam System Order in Australia
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 6:47AM CDT
Varian Medical Systems Inc. (VAR) won order from Australia-based Icon Group to supply 10 additional TrueBeam medical linear accelerators.
IRMD: 20.81 (-0.67), MASI: 52.56 (+0.04), VAR: 86.33 (+0.07), CRY: 12.29 (+0.09)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quorum Joins LIVE Coalition to Revolutionize Estate Planning

Shaking Up Estate Planning: Quorum Joins LIVE Coalition Here's a fresh shake-up in the world of estate planning. Quorum Federal Credit Union has thrown its hat into the ring as the latest member of the LIVE Coalition, a band of financial, legal, and tech wizards putting estate plans on a modern track. This marks them as the 70th player to dive into this alliance, pushing...

Managed Connectivity: Key to Modern Multifamily Living

Connectivity Runs the Modern Show Imagine moving into a shiny new apartment, where the biggest hassle isn't unpacking boxes but ensuring your gadgets get online smoothly. That's the reality of today's multifamily living, where the internet is more than a utility—it's the backbone of modern life. And if you think it's just about offering internet access, you're missing...

Neutonic Sets Sights on U.S. with Walmart Expansion

Neutonic Embarks on Major Expansion with Walmart Well, here we go. Neutonic is stepping up to the big leagues by planting its flag in nearly 1,000 Walmart stores across the U.S. This move lands them right in the thrumming heart of Walmart's new Mood & Mind beverage set. It's about time this brand brings its functional beverages to American shoppers already drained by...

Texas A&M-San Antonio's Research Expansion Momentum

Texas A&M-San Antonio's Rising Research Ambitions A rainy day in San Antonio and Texas A&M University-San Antonio seems to have set the stage for more than just another semester of record enrollment. They’ve just rolled in with an exhilarating $8 million in external grants this fiscal year, more than doubling last year’s haul of $3.6 million, in a bid to push their...

Karen Love's Retirement Marks End of an Era for TACHP

A Legacy Not Just Built, But Carved in Stone In the world of healthcare, folks like Karen Love don’t come around too often. She's stepping down from her post as President and CEO of Cook Children's Health Plan this month, and it feels like the end of a chapter for the Texas Association of Community Health Plans (TACHP). Love wasn't just an executive; she was a mover and...

MiniCo's New Desk: A Game Changer for E&S Market

A New Chapter in Industrial Casualty Look out, folks! MiniCo Insurance Agency is making waves with its latest launch. They're teaming up with Lloyd's of London, not to sell fish and chips, but to bring something groundbreaking in the insurance space—an industrial casualty trading desk. And if you’re raising an eyebrow wondering why this matters, let me break it down...

Rochester Memorial Installations: Key Timelines Revealed

There are times in life where patience isn’t just a virtue, it’s a necessity—memorial installations are one of those instances. In Rochester, NY, folks dealing with the loss of a loved one want more than just closures; they want to commemorate their people in a way that lasts. But how long does it take, really, to set these tributes in stone? Understanding the...

Fresh Leadership at Master Group: Langelier Steps In

Changing of the Guard: A Calculated Move It's not every day you see a company make a move as calculated and thoughtful as the one the Master Group just pulled. Rémy Langelier is set to transition into the shoes of CEO by early 2027, fresh off the heels of Louis St-Laurent. This isn't just any executive shuffle, folks—it's a strategic baton pass spawning an investment...

Hyundai's Record Q3 Sales: SUVs and Hybrids Lead

Hyundai's Drive to Record Q3 Sales When talking about market moves, Hyundai's recent figures speak louder than most quarterly bells. September 2026 marked a whirlwind of growth for Hyundai Motor America, reporting record-breaking sales numbers not just for the month, but for Q3 as a whole. With a 9% jump from September last year in total vehicle sales and a remarkable 3%...

Nukleus Launches Unified Platform for Athletes' Business

Leveling the Business Field for Athletes Athletes spend their lives fighting for every inch on the field, and now Nukleus is giving them the tools to hold ground off it. Why should they be the last ones to know their own business? Ashton Jeanty and Nukleus got tired of that narrative and kicked off a platform today with a real promise: putting an athlete's entire business...